申请人:The Procter & Gamble Company
公开号:US05399584A1
公开(公告)日:1995-03-21
The subject invention relates to methods for preventing or treating damage to the mucosal lining of the gastrointestinal tract of a human or lower animal by administering a safe and effective amount of a compound having the structure: ##STR1## wherein X and Y are each independently selected from O and S; R.sup.1, R.sup.2 and R.sup.3 are each independently selected from hydrogen, hydroxy, halo, unsubstituted or monosubstituted straight or branched C.sub.1 -C.sub.4 alkanyl, and unsubstituted or substituted straight or branched C.sub.1 -C.sub.4 alkanoxy; and each of R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is hydrogen or, if one or more of R.sup.1, R.sup.2 and R.sup.3 is other than hydrogen, each of R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is selected from hydrogen, halo, trifluoromethyl, and unsubstituted straight or branched C.sub.1 -C.sub.4 alkanyl.
该发明涉及一种方法,通过给予具有以下结构的化合物的安全有效量来预防或治疗人类或较低动物的胃肠道黏膜损伤:其中X和Y各自独立地选自O和S;R.sup.1、R.sup.2和R.sup.3各自独立地选自氢、羟基、卤素、未取代或单取代的直链或支链C.sub.1-C.sub.4烷基,以及未取代或取代的直链或支链C.sub.1-C.sub.4烷氧基;以及R.sup.4、R.sup.5、R.sup.6和R.sup.7中的每一个是氢或者,如果R.sup.1、R.sup.2和R.sup.3中的一个或多个不是氢,则R.sup.4、R.sup.5、R.sup.6和R.sup.7中的每一个选自氢、卤素、三氟甲基和未取代或取代的直链或支链C.sub.1-C.sub.4烷基。